Ameta Nihar, Jacob Mathews, Hasnain Shahbaz, Ramesh Gaurishankar
Department of Anaesthesiology and Critical Care, Armed Forces Medical College, Pune, Maharashtra, India.
J Anaesthesiol Clin Pharmacol. 2018 Jul-Sep;34(3):352-356. doi: 10.4103/joacp.JOACP_211_16.
Shivering after spinal anesthesia is a common complication and can occur in as many as 40%-70% of patients after regional anesthesia. This shivering, apart from its physiological and hemodynamic effects, has been described as even worse than surgical pain. The aim of the study was to evaluate and compare the effectiveness of prophylactic use of intravenous (IV) ketamine, dexmedetomidine, and tramadol for prevention of shivering after spinal anesthesia.
Two hundred American Society of Anesthesiologists physical status I and II patients subjected to spinal anesthesia were included in the study. The subjects were randomly divided into four groups to receive either ketamine 0.5 mg/kg IV or tramadol 0.5 mg/kg IV or dexmedetomidine 0.5 microgm/kg IV or 10 mL of 0.9% normal saline (NS). All the drugs/NS were administered as IV infusion over 10 min immediately before giving spinal anesthesia. Temperature (core and surface), heart rate, systolic blood pressure, diastolic blood pressure, and mean arterial pressure, peripheral oxygen saturation were assessed before giving the intrathecal injection and thereafter at 5 min intervals. Important side effects related to study drugs were also noted.
Shivering after spinal anesthesia was comparatively better controlled in group receiving dexmedetomidine as compared to other groups ( = 0.022). However, the use of dexmedetomidine was associated with significant hypotension which responded to single dose of mephentermine (3 mg IV). Dexmedetomidine is a better agent for prevention of shivering after spinal anesthesia as compared to ketamine and tramadol. It also provides adequate sedation and improves the surgical conditions.
Dexmedetomidine is effective and comparably better than tramadol or ketamine in preventing shivering after spinal anesthesia. Dexmedetomidine also provides sedation without respiratory depression and favorable surgical conditions. However, with its use a fall in blood pressure and heart rate is anticipated.
脊髓麻醉后寒战是一种常见并发症,在区域麻醉后的患者中发生率高达40%-70%。这种寒战,除了其生理和血流动力学影响外,甚至被描述为比手术疼痛更严重。本研究的目的是评估和比较预防性静脉注射氯胺酮、右美托咪定和曲马多预防脊髓麻醉后寒战的有效性。
本研究纳入了200例接受脊髓麻醉的美国麻醉医师协会身体状况I级和II级患者。受试者被随机分为四组,分别接受静脉注射0.5mg/kg氯胺酮、0.5mg/kg曲马多、0.5μg/kg右美托咪定或10mL 0.9%生理盐水(NS)。所有药物/NS均在脊髓麻醉前10分钟内静脉输注给药。在鞘内注射前及之后每隔5分钟评估体温(核心体温和体表温度)、心率、收缩压、舒张压、平均动脉压和外周血氧饱和度。还记录了与研究药物相关的重要副作用。
与其他组相比,接受右美托咪定的组脊髓麻醉后寒战得到了更好的控制(P = 0.022)。然而,右美托咪定的使用与显著的低血压有关,单剂量美芬丁胺(静脉注射3mg)可缓解。与氯胺酮和曲马多相比,右美托咪定是预防脊髓麻醉后寒战的更好药物。它还能提供足够的镇静作用并改善手术条件。
右美托咪定在预防脊髓麻醉后寒战方面有效,且比曲马多或氯胺酮更好。右美托咪定还能提供镇静作用而无呼吸抑制,且手术条件良好。然而,使用它预计会导致血压和心率下降。